Recent insights into mammalian natural and synthetic ex utero embryogenesis.


Journal

Current opinion in genetics & development
ISSN: 1879-0380
Titre abrégé: Curr Opin Genet Dev
Pays: England
ID NLM: 9111375

Informations de publication

Date de publication:
12 2022
Historique:
received: 24 04 2022
revised: 24 08 2022
accepted: 29 08 2022
pubmed: 1 10 2022
medline: 7 12 2022
entrez: 30 9 2022
Statut: ppublish

Résumé

Research on early postimplantation mammalian development has been limited by the small size and intrauterine confinement of the developing embryos. Owing to the inability to observe and manipulate living embryos at these stages in utero, the establishment of robust ex utero embryo-culture systems that capture prolonged periods of mouse development has been an important research goal. In the last few years, these methods have been significantly improved by the optimization and enhancement of in vitro culture systems sustaining embryo development during peri-implantation stages for several species, and more recently, proper growth of natural mouse embryos from pregastrulation to late organogenesis stages and of embryonic stem cell (ES)-derived synthetic embryo models until early organogenesis stages. Here, we discuss the most recent ex utero embryo-culture systems established to date for rodents, nonhuman primates, and humans. We emphasize their technical aspects and developmental timeframe and provide insights into the new opportunities that these methods will contribute to the study of natural and synthetic mammalian embryogenesis and the stem-cell field.

Identifiants

pubmed: 36179582
pii: S0959-437X(22)00097-1
doi: 10.1016/j.gde.2022.101988
pii:
doi:

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

101988

Informations de copyright

Copyright © 2022 Elsevier Ltd. All rights reserved.

Auteurs

Bernardo Oldak (B)

Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 7610001, Israel.

Alejandro Aguilera-Castrejon (A)

Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 7610001, Israel.

Jacob H Hanna (JH)

Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 7610001, Israel. Electronic address: jacob.hanna@weizmann.ac.il.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH